NCT03883022View on ClinicalTrials.gov

Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 3, 2018

Primary Completion Date

September 12, 2027

Study Completion Date

December 31, 2027

Conditions
Spinal FusionSpinal StenosisSpondylolisthesis
Interventions
DRUG

with U-VANCO (vancomycin hydrochloride)

1 gm or 2 gm mixed with autogenous cancellous bone graft

DRUG

without U-VANCO (vancomycin hydrochloride)

no vancomycin added

Trial Locations (1)

112

RECRUITING

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV